Cardiopulmonary Bypass Circuit Obstruction and Urgent Replacement After the Administration of Andexanet Alfa

J Cardiothorac Vasc Anesth. 2024 Mar;38(3):780-783. doi: 10.1053/j.jvca.2023.12.001. Epub 2023 Dec 6.

Authors

Yusaku Nozumi¹, Yuta Yonezawa², Kazuma Yunoki², Hiroyuki Mima²

Affiliations

¹ Department of Anesthesiology and Critical Care, Kobe City Medical Center General Hospital, 2-1-1 Minatojima Minamimachi, Chuo-Ku, Kobe City, Japan. Electronic address: youosoaokou@yahoo.co.jp.
² Department of Anesthesiology and Critical Care, Kobe City Medical Center General Hospital, 2-1-1 Minatojima Minamimachi, Chuo-Ku, Kobe City, Japan.

PMID: 38148268
DOI: 10.1053/j.jvca.2023.12.001

No abstract available

Keywords: andexanet alfa; cardiopulmonary bypass; edoxaban; heparin resistance.

Publication types

Case Reports

MeSH terms

Anticoagulants* / pharmacology
Blood Coagulation
Cardiopulmonary Bypass*
Factor Xa / pharmacology
Factor Xa Inhibitors / adverse effects
Humans
Recombinant Proteins / therapeutic use

Substances

PRT064445
Anticoagulants
Factor Xa
Recombinant Proteins
Factor Xa Inhibitors